Pa. Iredale et al., DIFFERENTIAL REGULATION OF CORTICOTROPIN-RELEASING FACTOR(1) RECEPTOREXPRESSION BY STRESS AND AGONIST TREATMENTS IN BRAIN AND CULTURED-CELLS, Molecular pharmacology, 50(5), 1996, pp. 1103-1110
Corticotropin-releasing factor (CRF) is known to play a major role in
coordinating neuroendocrine and behavioral responses to stress. We dem
onstrate that expression of the CRF(1) receptor (CRF-R1) is regulated
by stress in the brain and by agonist treatments in cultured cells. Ex
pression of CRF-R1 mRNA was decreased in the frontal cortex but increa
sed in the hippocampus by chronic unpredictable stress. Chronic cortic
osterone administration did not influence levels of CRF-R1 mRNA in eit
her region, suggesting that regulation of CRF-R1 expression is mediate
d by CRF itself or by another stress-related factor. Differential regu
lation of CRF-R1 mRNA by agonist treatment was also observed in two cu
ltured cell lines. In CATH.a cells, a neuron-derived cell line, incuba
tion with CRF decreased levels of CRF-R1 mRNA, whereas in AtT-20 cells
, a pituitary-derived cell line, agonist (CRF) treatment increased lev
els of CRF-R1 mRNA. Further studies demonstrated that the observed cha
nges in both cell lines could be accounted for by regulation of CRF-R1
gene transcription and not by altered mRNA stability. Furthermore, ag
onist-induced down-regulation of CRF-R1 transcription rate in CATH.a c
ells was found to be dependent on de novo protein synthesis, suggestin
g the involvement of an inducible repressor. The results show that dif
ferent cell types show differential transcriptional regulation of the
CRF-R1, which could explain the region-specific regulation of receptor
expression in the brain.